Scholar Rock (NASDAQ: SRRK; the "Company"), a late-stage biopharmaceutical company focused on advancing innovative treatments ...

The company granted stock options to purchase an aggregate of 208,350 shares of Nurix common stock and restricted stock unit awards (RSUs) representing an aggregate of 272,850 shares of Nurix common ...

Technology previously received a notice from the Staff of the Listing Qualifications Department of Nasdaq stating that because ...

MingZhu Logistics Holdings Limited ("MingZhu" or the "Company") (Nasdaq: YGMZ), an elite provider of logistics and transportation services to businesses, today announced that on February 13, 2025, it ...

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on February 6, 2025, the Compensation Committee of Acadia’s Board of Directors (the "Committee") granted inducement awards consisting of ...

Luokung Technology Corp. (NASDAQ: LKCO) (“Luokung” or the “Company”) today announced that on February 11, 2025, it has received a letter (the “Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”), ...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of ...

Holdings Limited announced that on February 13, 2025, it received a letter from the Nasdaq Stock Market LLC notifying ...

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted ...

Luokung Technology Corp. (NASDAQ: LKCO) ("Luokung" or the "Company") today announced that on February 11, 2025, it has received a letter (the "Letter") from ...

Oncolytics (ONCY) announced that it received a delinquency notification letter from Nasdaq indicating that the company is not currently in ...

AUSTIN, Texas-based Aspira Women's Health Inc. (AWH), currently trading at $0.24 and down over 60% year-to-date according to InvestingPro data, has resolved a compliance issue with Nasdaq's listing ...